Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Nanocapsules
Lessons to be learned from the 407 process.
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo.
In vitro derivation of macrophage from guinea pig bone marrow with human M-CSF.
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Ann Oncol. 2023 01; 34(1):48-60.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Dose-Response Relationship, Drug
Humans
Medical Oncology
Neoplasms
Randomized Controlled Trials as Topic
Research Design
Therapies, Investigational
authors with profiles
Mark Ratain